Literature DB >> 28921842

AnchorQuery: Rapid online virtual screening for small-molecule protein-protein interaction inhibitors.

David R Koes1, Alexander Dömling2, Carlos J Camacho1.   

Abstract

AnchorQuery (http://anchorquery.csb.pitt.edu) is a web application for rational structure-based design of protein-protein interaction (PPI) inhibitors. A specialized variant of pharmacophore search is used to rapidly screen libraries consisting of more than 31 million synthesizable compounds biased by design to preferentially target PPIs. Every library compound is accessible through one-step multi-component reaction (MCR) chemistry and contains an anchor motif that is bioisosteric to an amino acid residue. The inclusion of this anchor not only biases the compounds to interact with proteins, it also enables a rapid, sublinear time pharmacophore search algorithm. AnchorQuery provides all the tools necessary for users to perform online interactive virtual screens of millions of compounds, including pharmacophore elucidation and search, and enrichment analysis. Accessibility: AnchorQuery is freely accessible at http://anchorquery.csb.pitt.edu.
© 2017 The Protein Society.

Entities:  

Keywords:  compound libraries; multicomponent reactions; pharmacophore; small-molecules; virtual screening

Mesh:

Year:  2017        PMID: 28921842      PMCID: PMC5734307          DOI: 10.1002/pro.3303

Source DB:  PubMed          Journal:  Protein Sci        ISSN: 0961-8368            Impact factor:   6.725


  13 in total

1.  Dynamical view of the positions of key side chains in protein-protein recognition.

Authors:  S R Kimura; R C Brower; S Vajda; C J Camacho
Journal:  Biophys J       Date:  2001-02       Impact factor: 4.033

Review 2.  "Multi-component reactions : emerging chemistry in drug discovery" 'from xylocain to crixivan'.

Authors:  Christopher Hulme; Vijay Gore
Journal:  Curr Med Chem       Date:  2003-01       Impact factor: 4.530

Review 3.  Diversity of protein-protein interactions.

Authors:  Irene M A Nooren; Janet M Thornton
Journal:  EMBO J       Date:  2003-07-15       Impact factor: 11.598

4.  Anchor residues in protein-protein interactions.

Authors:  Deepa Rajamani; Spencer Thiel; Sandor Vajda; Carlos J Camacho
Journal:  Proc Natl Acad Sci U S A       Date:  2004-07-21       Impact factor: 11.205

Review 5.  Chemistry and biology of multicomponent reactions.

Authors:  Alexander Dömling; Wei Wang; Kan Wang
Journal:  Chem Rev       Date:  2012-03-22       Impact factor: 60.622

6.  Rational design and synthesis of 1,5-disubstituted tetrazoles as potent inhibitors of the MDM2-p53 interaction.

Authors:  Ewa Surmiak; Constantinos G Neochoritis; Bogdan Musielak; Aleksandra Twarda-Clapa; Katarzyna Kurpiewska; Grzegorz Dubin; Carlos Camacho; Tad A Holak; Alexander Dömling
Journal:  Eur J Med Chem       Date:  2016-11-16       Impact factor: 6.514

7.  Pharmer: efficient and exact pharmacophore search.

Authors:  David Ryan Koes; Carlos J Camacho
Journal:  J Chem Inf Model       Date:  2011-06-02       Impact factor: 4.956

8.  Scaffold hopping via ANCHOR.QUERY: β-lactams as potent p53-MDM2 antagonists.

Authors:  S Shaabani; C G Neochoritis; A Twarda-Clapa; B Musielak; T A Holak; A Dömling
Journal:  Medchemcomm       Date:  2017-03-15       Impact factor: 3.597

9.  Discovery of a Potent Allosteric Kinase Modulator by Combining Computational and Synthetic Methods.

Authors:  Edwin Kroon; Jörg O Schulze; Evelyn Süß; Carlos J Camacho; Ricardo M Biondi; Alexander Dömling
Journal:  Angew Chem Int Ed Engl       Date:  2015-09-04       Impact factor: 15.336

10.  PocketQuery: protein-protein interaction inhibitor starting points from protein-protein interaction structure.

Authors:  David Ryan Koes; Carlos J Camacho
Journal:  Nucleic Acids Res       Date:  2012-04-20       Impact factor: 16.971

View more
  12 in total

1.  Hitting on the move: Targeting intrinsically disordered protein states of the MDM2-p53 interaction.

Authors:  Constantinos G Neochoritis; Jack Atmaj; Aleksandra Twarda-Clapa; Ewa Surmiak; Lukasz Skalniak; Lisa-Maria Köhler; Damian Muszak; Katarzyna Kurpiewska; Justyna Kalinowska-Tłuścik; Barbara Beck; Tad A Holak; Alexander Dömling
Journal:  Eur J Med Chem       Date:  2019-08-06       Impact factor: 6.514

2.  A fluorinated indole-based MDM2 antagonist selectively inhibits the growth of p53wt osteosarcoma cells.

Authors:  Lukasz Skalniak; Aleksandra Twarda-Clapa; Constantinos G Neochoritis; Ewa Surmiak; Monika Machula; Aneta Wisniewska; Beata Labuzek; Ameena M Ali; Sylwia Krzanik; Grzegorz Dubin; Matthew Groves; Alexander Dömling; Tad A Holak
Journal:  FEBS J       Date:  2019-02-16       Impact factor: 5.542

3.  Novel Compounds Targeting the RNA-Binding Protein HuR. Structure-Based Design, Synthesis, and Interaction Studies.

Authors:  Serena Della Volpe; Rita Nasti; Michele Queirolo; M Yagiz Unver; Varsha K Jumde; Alexander Dömling; Francesca Vasile; Donatella Potenza; Francesca Alessandra Ambrosio; Giosué Costa; Stefano Alcaro; Chiara Zucal; Alessandro Provenzani; Marcello Di Giacomo; Daniela Rossi; Anna K H Hirsch; Simona Collina
Journal:  ACS Med Chem Lett       Date:  2019-01-21       Impact factor: 4.345

Review 4.  An overview of recent molecular dynamics applications as medicinal chemistry tools for the undruggable site challenge.

Authors:  Ugo Perricone; Maria Rita Gulotta; Jessica Lombino; Barbara Parrino; Stella Cascioferro; Patrizia Diana; Girolamo Cirrincione; Alessandro Padova
Journal:  Medchemcomm       Date:  2018-04-19       Impact factor: 3.597

Review 5.  Improving small molecule virtual screening strategies for the next generation of therapeutics.

Authors:  Bentley M Wingert; Carlos J Camacho
Journal:  Curr Opin Chem Biol       Date:  2018-06-17       Impact factor: 8.822

Review 6.  Computational Tools and Strategies to Develop Peptide-Based Inhibitors of Protein-Protein Interactions.

Authors:  Maxence Delaunay; Tâp Ha-Duong
Journal:  Methods Mol Biol       Date:  2022

Review 7.  Tetrazoles via Multicomponent Reactions.

Authors:  Constantinos G Neochoritis; Ting Zhao; Alexander Dömling
Journal:  Chem Rev       Date:  2019-02-01       Impact factor: 60.622

8.  Design of indole- and MCR-based macrocycles as p53-MDM2 antagonists.

Authors:  Constantinos G Neochoritis; Maryam Kazemi Miraki; Eman M M Abdelraheem; Ewa Surmiak; Tryfon Zarganes-Tzitzikas; Beata Łabuzek; Tad A Holak; Alexander Dömling
Journal:  Beilstein J Org Chem       Date:  2019-02-20       Impact factor: 2.883

Review 9.  Evolution of In Silico Strategies for Protein-Protein Interaction Drug Discovery.

Authors:  Stephani Joy Y Macalino; Shaherin Basith; Nina Abigail B Clavio; Hyerim Chang; Soosung Kang; Sun Choi
Journal:  Molecules       Date:  2018-08-06       Impact factor: 4.411

10.  Rapid Discovery of Aspartyl Protease Inhibitors Using an Anchoring Approach.

Authors:  Markella Konstantinidou; Francesca Magari; Fandi Sutanto; Jörg Haupenthal; Varsha R Jumde; M Yagiz Ünver; Andreas Heine; Carlos Jamie Camacho; Anna K H Hirsch; Gerhard Klebe; Alexander Dömling
Journal:  ChemMedChem       Date:  2020-03-18       Impact factor: 3.540

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.